Closely monitoring disease activity without starting medication immediately — an approach called watchful waiting — may raise the risk of relapse for people with mild IgG4-related disease (IgG4-RD), according to a real-world study from China. In people with IgG4-RD, watchful waiting is sometimes used as a strategy for patients…
